LIVE MARKET TRACKER :   BSE SENSEX   31524.68      |    NSE NIFTY 9837.40    
GLOBAL MARKETS :  NASDAQ 6216.5269   -0.0866%    |    FSI London 7323.98   -0.86%    |    NIKKEI Japan 19470.41   -1.18%
  USD GBP EUR CAD AUD INR
USD - 0.7768 0.8503 1.2582 1.2608 64.1600
GBP 1.2876 - 1.0950 1.6199 1.6237 82.5945
EUR 1.1766 0.9137 - 1.4794 1.4823 75.4197
CAD 0.7956 0.6179 0.6762 - 1.0026 51.0500
AUD 0.7930 0.6171 0.6744 0.9989 - 50.9100
INR 0.0156 0.0121 0.0133 0.0196 0.0197 -
Indian-Commodity  :  Corporate  :  Strides Shasun completes acquisition of strategic stake in Generic Partners Holdings

Strides Shasun completes acquisition of strategic stake in Generic Partners Holdings (17-Aug-2016)

Strides Shasun has completed the acquisition of strategic stake in Generic Partners Holdings, Australia and the above transaction has achieved closure. In February, the company had signed definitive agreements to acquire a strategic stake in Generic Partners Holdings, an Australian pharmaceutical supply and research company. Under the terms of the agreement, Strides Shasun will hold 51% of the issued capital of Generic Partners and the remaining equity will continue to be held by the current promoters. This was an all cash deal for an upfront consideration of AUD 15 Million and a commitment of AUD 10 Million to fund future R&D.

The acquisition provides Strides Shasun immediate access to 47 commercialized marketing authorizations making Arrow Pharmaceuticals, a wholly owned subsidiary of the company, the second largest generic pharmaceutical products company in Australia with a portfolio of over 180 molecules.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.


Top News Today
TCS features as 'Leader and Star Performer' in Everest Group report
(19-Aug-2017)

TCS features as Tata Consultancy Services (TCS) has been recognized as a Leader and Star Performer for Life Sciences Clinical and R&D IT Services by leading advisory and research firm, Everest Group, in its report,......click on news to read complete article.

DEN Networks gets NCLT's nod for scheme of arrangement
(19-Aug-2017)

DEN Networks gets NCLTDEN Networks has received honourable National Company Law Tribunal's (NCLT) approval for Scheme of Arrangement for merger of 23 subsidiaries and demerger of one of the subsidiary with a Wholly Owned Subsidiary......click on news to read complete article.

Monte Carlo Fashions planning to launch fitness, fashion wear range
(19-Aug-2017)

Monte Carlo Fashions planning to launch fitness, fashion wear rangeMonte Carlo Fashions is planning to launch Fitness and Fashion wear range in the name of 'ROCK IT'. The basic idea behind it is to introduce garments having an ideal combination of fitness and fashion.......click on news to read complete article.

International Stock News
US markets closed lower on Friday
(19-Aug-2017)

US markets closed lower on FridayThe US markets closed lower on Friday, to register another unsightly week of losses as low volumes and skittish investors left Wall Street especially vulnerable to pullbacks. Stocks shifted between gains......click on news to read complete article.

US markets closed lower on Friday
(19-Aug-2017)

US markets closed lower on FridayThe US markets closed lower on Friday, to register another unsightly week of losses as low volumes and skittish investors left Wall Street especially vulnerable to pullbacks. Stocks shifted between gains......click on news to read complete article.

US markets closed lower on Friday
(19-Aug-2017)

US markets closed lower on FridayThe US markets closed lower on Friday, to register another unsightly week of losses as low volumes and skittish investors left Wall Street especially vulnerable to pullbacks. Stocks shifted between gains......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.